Username

Password

Forgot Password?

Preview

Sign-in free and Explore the Exciting World of BiomedExperts:

Over 1.500.000 Profiles
More than 1.800 Organizations worldwide
State of the Art Network Visualizations

Manage your own Profile
Locate Experts in your Country/Region
Locate Experts in your 1. and 2. Level Network
Connect to Experts Worldwide

NetworkView

Gail Sonenshein

This is a preview profile on BiomedExperts - the first literature-based scientific social network. It brings the right researchers together and allows them to collaborate online. Collexis and Dell provide the BiomedExperts network of +1.5 Million pre-calculated profiles free of charge to researchers worldwide.

Research Profile (preview)

Chemicals & Drugs

Living Beings

Mice

Genes & Molecular Sequences

myc Genes

Physiology

Anatomy

Disorders

Breast Neoplasms

Sign-in to see full Profile

Network (preview)

Co-Publications
Name
16
Arsura, Marcello
12
Bellas, RE
12
Romieu-Mourez, Raphaëlle
12
Seldin, David
11
Wu, M
10
Sherr, David
10
Buckler, AJ
9
Duyao, Mabel
9
Jeay, Sébastien
7
Kim, Dong
7
Guo, Shangqin
7
Schauer, SL
7
Landesman-Bollag, Esther
7
Wang, Xiaobo
6
Trackman, Philip

Sign-in to see all Coauthors

Publications

TOP 3
Palamakumbura A H; Vora S R; Nugent M A; Kirsch K H; Sonenshein G E; Trackman P C
Lysyl oxidase propeptide inhibits prostate cancer cell growth by mechanisms that target FGF-2-cell binding and signaling.
Mineva Nora D; Wang Xiaobo; Yang Sanghwa; Ying Haoqiang; Xiao Zhi-Xiong J; Holick Michael F; Sonenshein Gail E
Inhibition of RelB by 1,25-dihydroxyvitamin D3 promotes sensitivity of breast cancer cells to radiation.
Min Chengyin; Yu Ziyang; Kirsch Kathrin H; Zhao Yingshe; Vora Siddharth R; Trackman Philip C; Spicer Douglas B; Rosenberg Lynn; Palmer Julie R; Sonenshein Gail E
A loss-of-function polymorphism in the propeptide domain of the LOX gene and breast cancer.

Sign-in to see all Publications

Sign in free and see...

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the visualized research activity
of experts around the globe

Sign-in to see more

Geonetwork of Gail Sonenshein (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

Sign-in to see more

All Publications

2009: Palamakumbura A H; Vora S R; Nugent M A; Kirsch K H; Sonenshein G E; Trackman P C
Lysyl oxidase propeptide inhibits prostate cancer cell growth by mechanisms that target FGF-2-cell binding and signaling.
Oncogene 2009;28(38):3390-400.
2009: Mineva Nora D; Wang Xiaobo; Yang Sanghwa; Ying Haoqiang; Xiao Zhi-Xiong J; Holick Michael F; Sonenshein Gail E
Inhibition of RelB by 1,25-dihydroxyvitamin D3 promotes sensitivity of breast cancer cells to radiation.
Journal of cellular physiology 2009;220(3):593-9.
2009: Min Chengyin; Yu Ziyang; Kirsch Kathrin H; Zhao Yingshe; Vora Siddharth R; Trackman Philip C; Spicer Douglas B; Rosenberg Lynn; Palmer Julie R; Sonenshein Gail E
A loss-of-function polymorphism in the propeptide domain of the LOX gene and breast cancer.
Cancer research 2009;69(16):6685-93.
2009: Wang Xiaobo; Belguise Karine; O'Neill Christine F; Sánchez-Morgan Nuria; Romagnoli Mathilde; Eddy Sean F; Mineva Nora D; Yu Ziyang; Min Chengyin; Trinkaus-Randall Vickery; Chalbos Dany; Sonenshein Gail E
RelB NF-kappaB represses estrogen receptor alpha expression via induction of the zinc finger protein Blimp1.
Molecular and cellular biology 2009;29(14):3832-44.
2009: Dominguez I; Sonenshein G E; Seldin D C
Protein kinase CK2 in health and disease: CK2 and its role in Wnt and NF-kappaB signaling: linking development and cancer.
Cellular and molecular life sciences : CMLS 2009;66(11-12):1850-7.
2009: Zhao Yingshe; Min Chengyin; Vora Siddharth R; Trackman Philip C; Sonenshein Gail E; Kirsch Kathrin H
The lysyl oxidase pro-peptide attenuates fibronectin-mediated activation of focal adhesion kinase and p130Cas in breast cancer cells.
The Journal of biological chemistry 2009;284(3):1385-93.
2008: Chandramohan Vidyalakshmi; Mineva Nora D; Burke Brian; Jeay Sébastien; Wu Min; Shen Jian; Yang William; Hann Stephen R; Sonenshein Gail E
c-Myc represses FOXO3a-mediated transcription of the gene encoding the p27(Kip1) cyclin dependent kinase inhibitor.
Journal of cellular biochemistry 2008;104(6):2091-106.
2008: Min Chengyin; Eddy Sean F; Sherr David H; Sonenshein Gail E
NF-kappaB and epithelial to mesenchymal transition of cancer.
Journal of cellular biochemistry 2008;104(3):733-44.
2008: Yang Xinhai; Solomon Sandra; Fraser Lauren R; Trombino Anthony F; Liu Donghui; Sonenshein Gail E; Hestermann Eli V; Sherr David H
Constitutive regulation of CYP1B1 by the aryl hydrocarbon receptor (AhR) in pre-malignant and malignant mammary tissue.
Journal of cellular biochemistry 2008;104(2):402-17.
2007: Belguise Karine; Guo Shangqin; Yang Shi; Rogers Adrianne E; Seldin David C; Sherr David H; Sonenshein Gail E
Green tea polyphenols reverse cooperation between c-Rel and CK2 that induces the aryl hydrocarbon receptor, slug, and an invasive phenotype.
Cancer research 2007;67(24):11742-50.
2007: Belguise Karine; Sonenshein Gail E
PKCtheta promotes c-Rel-driven mammary tumorigenesis in mice and humans by repressing estrogen receptor alpha synthesis.
The Journal of clinical investigation 2007;117(12):4009-21.
2007: Eddy Sean F; Kane Susan E; Sonenshein Gail E
Trastuzumab-resistant HER2-driven breast cancer cells are sensitive to epigallocatechin-3 gallate.
Cancer research 2007;67(19):9018-23.
2007: Wu Min; Min Chengyin; Wang Xiaobo; Yu Ziyang; Kirsch Kathrin H; Trackman Philip C; Sonenshein Gail E
Repression of BCL2 by the tumor suppressor activity of the lysyl oxidase propeptide inhibits transformed phenotype of lung and pancreatic cancer cells.
Cancer research 2007;67(13):6278-85.
2007: Belguise Karine; Guo Shangqin; Sonenshein Gail E
Activation of FOXO3a by the green tea polyphenol epigallocatechin-3-gallate induces estrogen receptor alpha expression reversing invasive phenotype of breast cancer cells.
Cancer research 2007;67(12):5763-70.
2007: Mineva Nora D; Rothstein Thomas L; Meyers John A; Lerner Adam; Sonenshein Gail E
CD40 ligand-mediated activation of the de novo RelB NF-kappaB synthesis pathway in transformed B cells promotes rescue from apoptosis.
The Journal of biological chemistry 2007;282(24):17475-85.
2007: Wang Xiaobo; Belguise Karine; Kersual Nathalie; Kirsch Kathrin H; Mineva Nora D; Galtier Florence; Chalbos Dany; Sonenshein Gail E
Oestrogen signalling inhibits invasive phenotype by repressing RelB and its target BCL2.
Nature cell biology 2007;9(4):470-8.
2007: Min Chengyin; Kirsch Kathrin H; Zhao Yingshe; Jeay Sébastien; Palamakumbura Amitha H; Trackman Philip C; Sonenshein Gail E
The tumor suppressor activity of the lysyl oxidase propeptide reverses the invasive phenotype of Her-2/neu-driven breast cancer.
Cancer research 2007;67(3):1105-12.
2006: Schlezinger Jennifer J; Liu Donghui; Farago Marganit; Seldin David C; Belguise Karine; Sonenshein Gail E; Sherr David H
A role for the aryl hydrocarbon receptor in mammary gland tumorigenesis.
Biological chemistry 2006;387(9):1175-87.
2006: Guo Shangqin; Lu Jun; Subramanian Aravind; Sonenshein Gail E
Microarray-assisted pathway analysis identifies mitogen-activated protein kinase signaling as a mediator of resistance to the green tea polyphenol epigallocatechin 3-gallate in her-2/neu-overexpressing breast cancer cells.
Cancer research 2006;66(10):5322-9.
2006: Shin Sangmin Ryan; Sánchez-Velar Nuria; Sherr David H; Sonenshein Gail E
7,12-dimethylbenz(a)anthracene treatment of a c-rel mouse mammary tumor cell line induces epithelial to mesenchymal transition via activation of nuclear factor-kappaB.
Cancer research 2006;66(5):2570-5.
2005: Eddy Sean F; Guo Shangqin; Demicco Elizabeth G; Romieu-Mourez Raphaëlle; Landesman-Bollag Esther; Seldin David C; Sonenshein Gail E
Inducible IkappaB kinase/IkappaB kinase epsilon expression is induced by CK2 and promotes aberrant nuclear factor-kappaB activation in breast cancer cells.
Cancer research 2005;65(24):11375-83.
2005: Guo Shangqin; Yang Sanghwa; Taylor Chad; Sonenshein Gail E
Green tea polyphenol epigallocatechin-3 gallate (EGCG) affects gene expression of breast cancer cells transformed by the carcinogen 7,12-dimethylbenz[a]anthracene.
The Journal of nutrition 2005;135(12 Suppl):2978S-2986S.
2005: Demicco Elizabeth G; Kavanagh Kathryn T; Romieu-Mourez Raphaëlle; Wang Xiaobo; Shin Sangmin R; Landesman-Bollag Esther; Seldin David C; Sonenshein Gail E
RelB/p52 NF-kappaB complexes rescue an early delay in mammary gland development in transgenic mice with targeted superrepressor IkappaB-alpha expression and promote carcinogenesis of the mammary gland.
Molecular and cellular biology 2005;25(22):10136-47.
2005: Murray Stephen A; Yang Shi; Demicco Elizabeth; Ying Haoqiang; Sherr David H; Hafer Laurie J; Rogers Adrianne E; Sonenshein Gail E; Xiao Zhi-Xiong Jim
Increased expression of MDM2, cyclin D1, and p27Kip1 in carcinogen-induced rat mammary tumors.
Journal of cellular biochemistry 2005;95(5):875-84.
2005: Hofmann Claudia S; Wang Xiaobo; Sullivan Christopher P; Toselli Paul; Stone Phillip J; McLean Sean E; Mecham Robert P; Schreiber Barbara M; Sonenshein Gail E
B-Myb represses elastin gene expression in aortic smooth muscle cells.
The Journal of biological chemistry 2005;280(9):7694-701.
2005: Wang Xiaobo; Sonenshein Gail E
Induction of the RelB NF-kappaB subunit by the cytomegalovirus IE1 protein is mediated via Jun kinase and c-Jun/Fra-2 AP-1 complexes.
Journal of virology 2005;79(1):95-105.
2005: Currier Nicolas; Solomon Sandra E; Demicco Elizabeth G; Chang Donny L F; Farago Marganit; Ying Haoqiang; Dominguez Isabel; Sonenshein Gail E; Cardiff Robert D; Xiao Zhi-Xiong Jim; Sherr David H; Seldin David C
Oncogenic signaling pathways activated in DMBA-induced mouse mammary tumors.
Toxicologic pathology 2005;33(6):726-37.
2004: Guo Shangqin; Sonenshein Gail E
Forkhead box transcription factor FOXO3a regulates estrogen receptor alpha expression and is repressed by the Her-2/neu/phosphatidylinositol 3-kinase/Akt signaling pathway.
Molecular and cellular biology 2004;24(19):8681-90.
2004: Palamakumbura Amitha H; Jeay Sébastien; Guo Ying; Pischon Nicole; Sommer Pascal; Sonenshein Gail E; Trackman Philip C
The propeptide domain of lysyl oxidase induces phenotypic reversion of ras-transformed cells.
The Journal of biological chemistry 2004;279(39):40593-600.
2004: Hofmann Claudia S; Sullivan Christopher P; Jiang Hao-Yuan; Stone Phillip J; Toselli Paul; Reis Ernane D; Chereshnev Igor; Schreiber Barbara M; Sonenshein Gail E
B-Myb represses vascular smooth muscle cell collagen gene expression and inhibits neointima formation after arterial injury.
Arteriosclerosis, thrombosis, and vascular biology 2004;24(9):1608-13.
2004: Chandramohan Vidyalakshmi; Jeay Sébastien; Pianetti Stefania; Sonenshein Gail E
Reciprocal control of Forkhead box O 3a and c-Myc via the phosphatidylinositol 3-kinase pathway coordinately regulates p27Kip1 levels.
Journal of immunology (Baltimore, Md. : 1950) 2004;172(9):5522-7.
2003: Cavin Lakita G; Romieu-Mourez Raphaelle; Panta Ganesh R; Sun Jiyuan; Factor Valentina M; Thorgeirsson Snorri S; Sonenshein Gail E; Arsura Marcello
Inhibition of CK2 activity by TGF-beta1 promotes IkappaB-alpha protein stabilization and apoptosis of immortalized hepatocytes.
Hepatology (Baltimore, Md.) 2003;38(6):1540-51.
2003: Romieu-Mourez Raphaëlle; Kim Dong W; Shin Sang Min; Demicco Elizabeth G; Landesman-Bollag Esther; Seldin David C; Cardiff Robert D; Sonenshein Gail E
Mouse mammary tumor virus c-rel transgenic mice develop mammary tumors.
Molecular and cellular biology 2003;23(16):5738-54.
2003: Petrovas Constantinos; Jeay Sébastien; Lewis Robert E; Sonenshein Gail E
B-Myb repressor function is regulated by cyclin A phosphorylation and sequences within the C-terminal domain.
Oncogene 2003;22(13):2011-20.
2003: Jeay Sébastien; Pianetti Stefania; Kagan Herbert M; Sonenshein Gail E
Lysyl oxidase inhibits ras-mediated transformation by preventing activation of NF-kappa B.
Molecular and cellular biology 2003;23(7):2251-63.
2003: Hofmann Claudia S; Sonenshein Gail E
Green tea polyphenol epigallocatechin-3 gallate induces apoptosis of proliferating vascular smooth muscle cells via activation of p53.
The FASEB journal : official publication of the Federation of American Societies for Experimental Biology 2003;17(6):702-4.
2003: Arsura Marcello; Panta Ganesh R; Bilyeu Jennifer D; Cavin Lakita G; Sovak Mika A; Oliver Aundrea A; Factor Valentina; Heuchel Rainer; Mercurio Frank; Thorgeirsson Snorri S; Sonenshein Gail E
Transient activation of NF-kappaB through a TAK1/IKK kinase pathway by TGF-beta1 inhibits AP-1/SMAD signaling and apoptosis: implications in liver tumor formation.
Oncogene 2003;22(3):412-25.
2002: Romieu-Mourez Raphaëlle; Landesman-Bollag Esther; Seldin David C; Sonenshein Gail E
Protein kinase CK2 promotes aberrant activation of nuclear factor-kappaB, transformed phenotype, and survival of breast cancer cells.
Cancer research 2002;62(22):6770-8.
2002: Jiang H Y; Petrovas Constantinos; Sonenshein Gail E
RelB-p50 NF-kappa B complexes are selectively induced by cytomegalovirus immediate-early protein 1: differential regulation of Bcl-x(L) promoter activity by NF-kappa B family members.
Journal of virology 2002;76(11):5737-47.
2002: Jeay Sébastien; Sonenshein Gail E; Postel-Vinay Marie Catherine; Kelly Paul A; Baixeras Elena
Growth hormone can act as a cytokine controlling survival and proliferation of immune cells: new insights into signaling pathways.
Molecular and cellular endocrinology 2002;188(1-2):1-7.
2002: Pianetti Stefania; Guo Shangqin; Kavanagh Kathryn T; Sonenshein Gail E
Green tea polyphenol epigallocatechin-3 gallate inhibits Her-2/neu signaling, proliferation, and transformed phenotype of breast cancer cells.
Cancer research 2002;62(3):652-5.
2001: Landesman-Bollag E; Song D H; Romieu-Mourez R; Sussman D J; Cardiff R D; Sonenshein G E; Seldin D C
Protein kinase CK2: signaling and tumorigenesis in the mammary gland.
Molecular and cellular biochemistry 2001;227(1-2):153-65.
2001: Shen J; Channavajhala P; Seldin D C; Sonenshein G E
Phosphorylation by the protein kinase CK2 promotes calpain-mediated degradation of IkappaBalpha.
Journal of immunology (Baltimore, Md. : 1950) 2001;167(9):4919-25.
2001: Factor V; Oliver A L; Panta G R; Thorgeirsson S S; Sonenshein G E; Arsura M
Roles of Akt/PKB and IKK complex in constitutive induction of NF-kappaB in hepatocellular carcinomas of transforming growth factor alpha/c-myc transgenic mice.
Hepatology (Baltimore, Md.) 2001;34(1):32-41.
2001: Landesman-Bollag E; Romieu-Mourez R; Song D H; Sonenshein G E; Cardiff R D; Seldin D C
Protein kinase CK2 in mammary gland tumorigenesis.
Oncogene 2001;20(25):3247-57.
2001: Romieu-Mourez R; Landesman-Bollag E; Seldin D C; Traish A M; Mercurio F; Sonenshein G E
Roles of IKK kinases and protein kinase CK2 in activation of nuclear factor-kappaB in breast cancer.
Cancer research 2001;61(9):3810-8.
2001: Yang W; Shen J; Wu M; Arsura M; FitzGerald M; Suldan Z; Kim D W; Hofmann C S; Pianetti S; Romieu-Mourez R; Freedman L P; Sonenshein G E
Repression of transcription of the p27(Kip1) cyclin-dependent kinase inhibitor gene by c-Myc.
Oncogene 2001;20(14):1688-702.
2001: Pianetti S; Arsura M; Romieu-Mourez R; Coffey R J; Sonenshein G E
Her-2/neu overexpression induces NF-kappaB via a PI3-kinase/Akt pathway involving calpain-mediated degradation of IkappaB-alpha that can be inhibited by the tumor suppressor PTEN.
Oncogene 2001;20(11):1287-99.
2001: Jeay S; Sonenshein G E; Kelly P A; Postel-Vinay M C; Baixeras E
Growth hormone exerts antiapoptotic and proliferative effects through two different pathways involving nuclear factor-kappaB and phosphatidylinositol 3-kinase.
Endocrinology 2001;142(1):147-56.
2001: Kavanagh K T; Hafer L J; Kim D W; Mann K K; Sherr D H; Rogers A E; Sonenshein G E
Green tea extracts decrease carcinogen-induced mammary tumor burden in rats and rate of breast cancer cell proliferation in culture.
Journal of cellular biochemistry 2001;82(3):387-98.
2000: Kim D W; Gazourian L; Quadri S A; Romieu-Mourez R; Sherr D H; Sonenshein G E
The RelA NF-kappaB subunit and the aryl hydrocarbon receptor (AhR) cooperate to transactivate the c-myc promoter in mammary cells.
Oncogene 2000;19(48):5498-506.
2000: Trombino A F; Near R I; Matulka R A; Yang S; Hafer L J; Toselli P A; Kim D W; Rogers A E; Sonenshein G E; Sherr D H
Expression of the aryl hydrocarbon receptor/transcription factor (AhR) and AhR-regulated CYP1 gene transcripts in a rat model of mammary tumorigenesis.
Breast cancer research and treatment 2000;63(2):117-31.
2000: Kypreos K E; Birk D; Trinkaus-Randall V; Hartmann D J; Sonenshein G E
Type V collagen regulates the assembly of collagen fibrils in cultures of bovine vascular smooth muscle cells.
Journal of cellular biochemistry 2000;80(1):146-55.
2000: Arsura M; Hofmann C S; Golay J; Introna M; Sonenshein G E
A-myb rescues murine B-cell lymphomas from IgM-receptor-mediated apoptosis through c-myc transcriptional regulation.
Blood 2000;96(3):1013-20.
2000: Arsura M; Mercurio F; Oliver A L; Thorgeirsson S S; Sonenshein G E
Role of the IkappaB kinase complex in oncogenic Ras- and Raf-mediated transformation of rat liver epithelial cells.
Molecular and cellular biology 2000;20(15):5381-91.
2000: Jeay S; Sonenshein G E; Postel-Vinay M C; Baixeras E
Growth hormone prevents apoptosis through activation of nuclear factor-kappaB in interleukin-3-dependent Ba/F3 cell line.
Molecular endocrinology (Baltimore, Md.) 2000;14(5):650-61.
2000: Kim D W; Sovak M A; Zanieski G; Nonet G; Romieu-Mourez R; Lau A W; Hafer L J; Yaswen P; Stampfer M; Rogers A E; Russo J; Sonenshein G E
Activation of NF-kappaB/Rel occurs early during neoplastic transformation of mammary cells.
Carcinogenesis 2000;21(5):871-9.
1999: Wu M; Bellas R E; Shen J; Yang W; Sonenshein G E
Increased p27Kip1 cyclin-dependent kinase inhibitor gene expression following anti-IgM treatment promotes apoptosis of WEHI 231 B cells.
Journal of immunology (Baltimore, Md. : 1950) 1999;163(12):6530-5.
1999: Sovak M A; Arsura M; Zanieski G; Kavanagh K T; Sonenshein G E
The inhibitory effects of transforming growth factor beta1 on breast cancer cell proliferation are mediated through regulation of aberrant nuclear factor-kappaB/Rel expression.
Cell growth & differentiation : the molecular biology journal of the American Association for Cancer Research 1999;10(8):537-44.
1999: Kypreos K E; Marhamati D J; Sonenshein G E
B-Myb represses trans-activation of the Col5A2 collagen promoter indirectly via inhibition of binding of factors interacting with positive elements within the first exon.
Matrix biology : journal of the International Society for Matrix Biology 1999;18(3):275-85.
1999: Bellas R E; Sonenshein G E
Nuclear factor kappaB cooperates with c-Myc in promoting murine hepatocyte survival in a manner independent of p53 tumor suppressor function.
Cell growth & differentiation : the molecular biology journal of the American Association for Cancer Research 1999;10(5):287-94.
1999: FitzGerald M J; Arsura M; Bellas R E; Yang W; Wu M; Chin L; Mann K K; DePinho R A; Sonenshein G E
Differential effects of the widely expressed dMax splice variant of Max on E-box vs initiator element-mediated regulation by c-Myc.
Oncogene 1999;18(15):2489-98.
1998: Kypreos K E; Nugent M A; Sonenshein G E
Basic fibroblast growth factor-induced decrease in type I collagen gene transcription is mediated by B-myb.
Cell growth & differentiation : the molecular biology journal of the American Association for Cancer Research 1998;9(9):723-30.
1998: Wu M; Bellas R E; Shen J; Sonenshein G E
Roles of the tumor suppressor p53 and the cyclin-dependent kinase inhibitor p21WAF1/CIP1 in receptor-mediated apoptosis of WEHI 231 B lymphoma cells.
The Journal of experimental medicine 1998;187(10):1671-9.
1998: Schauer S L; Bellas R E; Sonenshein G E
Dominant signals leading to inhibitor kappaB protein degradation mediate CD40 ligand rescue of WEHI 231 immature B cells from receptor-mediated apoptosis.
Journal of immunology (Baltimore, Md. : 1950) 1998;160(9):4398-405.
1998: Lee J S; Kypreos K E; Sonenshein G E
Synchronization of cultured vascular smooth muscle cells following reversal of quiescence induced by treatment with the antioxidant N-acetylcysteine.
Experimental cell research 1998;239(2):447-53.
1998: Kypreos K E; Sonenshein G E
Basic fibroblast growth factor decreases type V/XI collagen expression in cultured bovine aortic smooth muscle cells.
Journal of cellular biochemistry 1998;68(2):247-58.
1997: Sovak M A; Bellas R E; Kim D W; Zanieski G J; Rogers A E; Traish A M; Sonenshein G E
Aberrant nuclear factor-kappaB/Rel expression and the pathogenesis of breast cancer.
The Journal of clinical investigation 1997;100(12):2952-60.
1997: Arsura M; FitzGerald M J; Fausto N; Sonenshein G E
Nuclear factor-kappaB/Rel blocks transforming growth factor beta1-induced apoptosis of murine hepatocyte cell lines.
Cell growth & differentiation : the molecular biology journal of the American Association for Cancer Research 1997;8(10):1049-59.
1997: Bellas R E; FitzGerald M J; Fausto N; Sonenshein G E
Inhibition of NF-kappa B activity induces apoptosis in murine hepatocytes.
The American journal of pathology 1997;151(4):891-6.
1997: Matsui K; Omura S; Cui H; Schauer S L; Sonenshein G E; Ju S T
Proteasome regulation of Fas ligand cytotoxicity.
European journal of immunology 1997;27(9):2269-78.
1997: Cui H; Matsui K; Omura S; Schauer S L; Matulka R A; Sonenshein G E; Ju S T
Proteasome regulation of activation-induced T cell death.
Proceedings of the National Academy of Sciences of the United States of America 1997;94(14):7515-20.
1997: Marhamati D J; Bellas R E; Arsura M; Kypreos K E; Sonenshein G E
A-myb is expressed in bovine vascular smooth muscle cells during the late G1-to-S phase transition and cooperates with c-myc to mediate progression to S phase.
Molecular and cellular biology 1997;17(5):2448-57.
1997: Sonenshein G E
Rel/NF-kappa B transcription factors and the control of apoptosis.
Seminars in cancer biology 1997;8(2):113-9.
1997: Sonenshein G E
Down-modulation of c-myc expression induces apoptosis of B lymphocyte models of tolerance via clonal deletion.
Journal of immunology (Baltimore, Md. : 1950) 1997;158(5):1994-7.
1997: Wu M; Yang W; Bellas R E; Schauer S L; FitzGerald M J; Lee H; Sonenshein G E
c-myc promotes survival of WEHI 231 B lymphoma cells from apoptosis.
Current topics in microbiology and immunology 1997;224():91-101.
1996: Wu M; Lee H; Bellas R E; Schauer S L; Arsura M; Katz D; FitzGerald M J; Rothstein T L; Sherr D H; Sonenshein G E
Inhibition of NF-kappaB/Rel induces apoptosis of murine B cells.
The EMBO journal 1996;15(17):4682-90.
1996: Wu M; Arsura M; Bellas R E; FitzGerald M J; Lee H; Schauer S L; Sherr D H; Sonenshein G E
Inhibition of c-myc expression induces apoptosis of WEHI 231 murine B cells.
Molecular and cellular biology 1996;16(9):5015-25.
1996: Arsura M; Wu M; Sonenshein G E
TGF beta 1 inhibits NF-kappa B/Rel activity inducing apoptosis of B cells: transcriptional activation of I kappa B alpha.
Immunity 1996;5(1):31-40.
1996: Schauer S L; Wang Z; Sonenshein G E; Rothstein T L
Maintenance of nuclear factor-kappa B/Rel and c-myc expression during CD40 ligand rescue of WEHI 231 early B cells from receptor-mediated apoptosis through modulation of I kappa B proteins.
Journal of immunology (Baltimore, Md. : 1950) 1996;157(1):81-6.
1996: Marhamati D J; Sonenshein G E
B-Myb expression in vascular smooth muscle cells occurs in a cell cycle-dependent fashion and down-regulates promoter activity of type I collagen genes.
The Journal of biological chemistry 1996;271(7):3359-65.
1995: Arsura M; Deshpande A; Hann S R; Sonenshein G E
Variant Max protein, derived by alternative splicing, associates with c-Myc in vivo and inhibits transactivation.
Molecular and cellular biology 1995;15(12):6702-9.
1995: Bellas R E; Lee J S; Sonenshein G E
Expression of a constitutive NF-kappa B-like activity is essential for proliferation of cultured bovine vascular smooth muscle cells.
The Journal of clinical investigation 1995;96(5):2521-7.
1995: Lee H; Arsura M; Wu M; Duyao M; Buckler A J; Sonenshein G E
Role of Rel-related factors in control of c-myc gene transcription in receptor-mediated apoptosis of the murine B cell WEHI 231 line.
The Journal of experimental medicine 1995;181(3):1169-77.
1995: Lee H; Wu M; La Rosa F A; Duyao M P; Buckler A J; Sonenshein G E
Role of the Rel-family of transcription factors in the regulation of c-myc gene transcription and apoptosis of WEHI 231 murine B-cells.
Current topics in microbiology and immunology 1995;194():247-55.
1994: Lawrence R; Chang L J; Siebenlist U; Bressler P; Sonenshein G E
Vascular smooth muscle cells express a constitutive NF-kappa B-like activity.
The Journal of biological chemistry 1994;269(46):28913-8.
1994: Lawrence R; Hartmann D J; Sonenshein G E
Transforming growth factor beta 1 stimulates type V collagen expression in bovine vascular smooth muscle cells.
The Journal of biological chemistry 1994;269(13):9603-9.
1994: Maheswaran S; Lee H; Sonenshein G E
Intracellular association of the protein product of the c-myc oncogene with the TATA-binding protein.
Molecular and cellular biology 1994;14(2):1147-52.
1994: La Rosa F A; Pierce J W; Sonenshein G E
Differential regulation of the c-myc oncogene promoter by the NF-kappa B rel family of transcription factors.
Molecular and cellular biology 1994;14(2):1039-44.
1993: Wolfe B L; Rich C B; Goud H D; Terpstra A J; Bashir M; Rosenbloom J; Sonenshein G E; Foster J A
Insulin-like growth factor-I regulates transcription of the elastin gene.
The Journal of biological chemistry 1993;268(17):12418-26.
1992: Kessler D J; Spicer D B; La Rosa F A; Sonenshein G E
A novel NF-kappa B element within exon 1 of the murine c-myc gene.
Oncogene 1992;7(12):2447-53.
1992: Kessler D J; Duyao M P; Spicer D B; Sonenshein G E
NF-kappa B-like factors mediate interleukin 1 induction of c-myc gene transcription in fibroblasts.
The Journal of experimental medicine 1992;176(3):787-92.
1992: Duyao M P; Kessler D J; Spicer D B; Bartholomew C; Cleveland J L; Siekevitz M; Sonenshein G E
Transactivation of the c-myc promoter by human T cell leukemia virus type 1 tax is mediated by NF kappa B.
The Journal of biological chemistry 1992;267(23):16288-91.
1992: Yu X; Dluz S; Graves D T; Zhang L; Antoniades H N; Hollander W; Prusty S; Valente A J; Schwartz C J; Sonenshein G E
Elevated expression of monocyte chemoattractant protein 1 by vascular smooth muscle cells in hypercholesterolemic primates.
Proceedings of the National Academy of Sciences of the United States of America 1992;89(15):6953-7.
1992: Duyao M P; Kessler D J; Spicer D B; Sonenshein G E
Transactivation of the murine c-myc gene by HTLV-1 tax is mediated by NFkB.
AIDS research and human retroviruses 1992;8(5):752-4.
1992: Spicer D B; Sonenshein G E
An antisense promoter of the murine c-myc gene is localized within intron 2.
Molecular and cellular biology 1992;12(3):1324-9.
1992: Brown K E; Kindy M S; Sonenshein G E
Expression of the c-myb proto-oncogene in bovine vascular smooth muscle cells.
The Journal of biological chemistry 1992;267(7):4625-30.
1992: Duyao M P; Kessler D J; Spicer D B; Sonenshein G E
Transactivation of the c-myc gene by HTLV-1 tax is mediated by NFkB.
Current topics in microbiology and immunology 1992;182():421-4.
1991: Brown K E; Lawrence R; Sonenshein G E
Concerted modulation of alpha 1(XI) and alpha 2(V) collagen mRNAs in bovine vascular smooth muscle cells.
The Journal of biological chemistry 1991;266(34):23268-73.
1991: Maheswaran S; McCormack J E; Sonenshein G E
Changes in phosphorylation of myc oncogene and RB antioncogene protein products during growth arrest of the murine lymphoma WEHI 231 cell line.
Oncogene 1991;6(11):1965-71.
1991: Chang Y; Spicer D B; Sonenshein G E
Effects of IL-3 on promoter usage, attenuation and antisense transcription of the c-myc oncogene in the IL-3-dependent Ba/F3 early pre-B cell line.
Oncogene 1991;6(11):1979-82.
1990: Buckler A J; Rothstein T L; Sonenshein G E
Transcriptional control of c-myc gene expression during stimulation of murine B lymphocytes.
Journal of immunology (Baltimore, Md. : 1950) 1990;145(2):732-6.
1990: Duyao M P; Buckler A J; Sonenshein G E
Interaction of an NF-kappa B-like factor with a site upstream of the c-myc promoter.
Proceedings of the National Academy of Sciences of the United States of America 1990;87(12):4727-31.
1990: Duyao M P; Kessler D J; Spicer D B; Sonenshein G E
Binding of NF-KB-like factors to regulatory sequences of the c-myc gene.
Current topics in microbiology and immunology 1990;166():211-20.
1988: Kindy M S; Chang C J; Sonenshein G E
Serum deprivation of vascular smooth muscle cells enhances collagen gene expression.
The Journal of biological chemistry 1988;263(23):11426-30.
1988: Buckler A J; Vie H; Sonenshein G E; Miller R A
Defective T lymphocytes in old mice. Diminished production of mature c-myc RNA after mitogen exposure not attributable to alterations in transcription or RNA stability.
Journal of immunology (Baltimore, Md. : 1950) 1988;140(7):2442-6.
1988: Buckler A J; Rothstein T L; Sonenshein G E
Two-step stimulation of B lymphocytes to enter DNA synthesis: synergy between anti-immunoglobulin antibody and cytochalasin on expression of c-myc and a G1-specific gene.
Molecular and cellular biology 1988;8(3):1371-5.
1988: Buckler A J; Kessler D J; Duyao M P; Rothstein T L; Sonenshein G E
Regulation of c-myc gene transcription in B lymphocytes: mechanisms of negative and positive control.
Current topics in microbiology and immunology 1988;141():238-46.
1987: Kindy M S; McCormack J E; Buckler A J; Levine R A; Sonenshein G E
Independent regulation of transcription of the two strands of the c-myc gene.
Molecular and cellular biology 1987;7(8):2857-62.
1986: Levine R A; McCormack J E; Buckler A; Sonenshein G E
Transcriptional and posttranscriptional control of c-myc gene expression in WEHI 231 cells.
Molecular and cellular biology 1986;6(11):4112-6.
1986: Pepe V H; Sonenshein G E; Yoshimura M I; Shulman M J
Gene transfer of immunoglobulin light chain restores heavy chain secretion.
Journal of immunology (Baltimore, Md. : 1950) 1986;137(7):2367-72.
1986: Levine R A; McCormack J E; Buckler A; Sonenshein G E
Complex regulation of c-myc gene expression in a murine B cell lymphoma.
Current topics in microbiology and immunology 1986;132():305-12.
1984: McCormack J E; Pepe V H; Kent R B; Dean M; Marshak-Rothstein A; Sonenshein G E
Specific regulation of c-myc oncogene expression in a murine B-cell lymphoma.
Proceedings of the National Academy of Sciences of the United States of America 1984;81(17):5546-50.
1984: Ponte P A; Dean M; Pepe V H; Sonenshein G E
Overproduction of immunoglobulin mRNA by a murine myeloma MOPC 315 variant cell line.
Journal of immunology (Baltimore, Md. : 1950) 1984;133(1):476-81.
1984: McCormack J E; Kent R B; Pepe V H; Dean M; Marshak-Rothstein A; Sonenshein G E
Immune regulation of the c-myc oncogene in a murine B lymphoma.
Current topics in microbiology and immunology 1984;113():127-32.
1983: Dean M; Kent R B; Sonenshein G E
Transcriptional activation of immunoglobulin alpha heavy-chain genes by translocation of the c-myc oncogene.
Nature 1983;305(5933):443-6.
1981: Ponte P A; Siekevitz M; Schwartz R C; Gefter M L; Sonenshein G E
Transcription of immunoglobulin heavy-chain sequences from the excluded allele.
Nature 1981;291(5816):594-6.

Sign-in to see more